(Q34431326)

2 August 2017

title

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms (English)

1 reference

2 August 2017

1 reference

1 reference

systolic heart failure

1 reference

4

Martin R Cowie

1 reference

2 August 2017

5

Faiez Zannad

1 reference

2 August 2017

9

Bertram Pitt

1 reference

2 August 2017

Dirk J van Veldhuisen

7

object named as

Dirk J van Veldhuisen

1 reference

2 August 2017

6

Henry Krum

1 reference

2 August 2017

10

John J V McMurray

1 reference

2 August 2017

3

Ron Akehurst

1 reference

2 August 2017

Dawn Lee

1

1 reference

2 August 2017

Koo Wilson

2

1 reference

2 August 2017

John Vincent

8

1 reference

2 August 2017

Eplerenone in Mild Patients Hospitalization And Survival Study in Heart Failure (EMPHASIS-HF) Study

11

1 reference

2 August 2017

language of work or name

English

0 references

publication date

3 July 2014

1 reference

2 August 2017

1 reference

2 August 2017

volume

100

1 reference

2 August 2017

issue

21

1 reference

2 August 2017

page(s)

1681-1687

1 reference

Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215293

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215293

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215293

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215293

Clinical epidemiology of heart failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215293

Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215293

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215293

The current cost of heart failure to the National Health Service in the UK.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215293

Survival of patients with a new diagnosis of heart failure: a population based study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215293

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4215293

Eplerenone in patients with systolic heart failure and mild symptoms

6 July 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

Discrete event simulation: the preferred technique for health economic evaluations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

Catalogue of EQ-5D scores for the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

An economic analysis of specialist heart failure nurse management in the UK; can we afford not to implement it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

Factors determining utility measured with the EQ-5D in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

Reduced costs with bisoprolol treatment for heart failure; an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-305673

10.1136/HEARTJNL-2014-305673

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference